This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignee: Deutsches Krebsforschungszentrum. Active years: 2010.
Company Filing History:
Years Active: 2010
Title: Susanne Stumm: Innovator in Preeclampsia Research
Introduction
Susanne Stumm is a notable inventor based in Leimen, Germany. She has made significant contributions to the field of medical research, particularly in the diagnosis and treatment of preeclampsia. Her innovative work has the potential to impact many lives by improving healthcare outcomes for expectant mothers.
Latest Patents
Susanne Stumm holds a patent for the "Use of ADAM 12 for diagnosis and therapy of preeclampsia." This invention highlights the important role of ADAM 12, ADAM 12-L, and ADAM 12-S in preeclampsia and related disorders. The patent outlines the use of these genes and their products, as well as ligands that bind to them, in the diagnosis and treatment of preeclampsia and associated syndromes. Furthermore, it discusses the potential for using additional genes and combinations thereof in diagnosing these conditions.
Career Highlights
Throughout her career, Susanne Stumm has worked with prestigious organizations, including the Deutsches Krebsforschungszentrum and Robert Bosch. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of her notable coworkers include Sabine Gack and Peter Lichter. Their collaborative efforts have further advanced the understanding of preeclampsia and its related disorders.
Conclusion
Susanne Stumm's innovative work in the field of preeclampsia research exemplifies the impact that dedicated inventors can have on healthcare. Her contributions through her patent and collaborations with esteemed colleagues continue to pave the way for advancements in medical science.